References
- Kawashima Y., Takeuchi H., Handa T., Thiele W. J., Deen D. P., McGinity J. W. Aqueous-based coatings in matrix tablets formulations. Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, J. W. McGinity. Marcel Dekker, New York 1989; 151–185
- Kané Y., Rambaud J., Maillols H., Laget J. P., Gaudy D., Delonca H. Drug Dev. Ind. Pharm. 1994; 20(6)1021–1034
- British Pharmacopoeia. 1993
- Pharmaeuropa 1993; 5(3)182, European Council
- Mack Easton, Rockville 1995; 1795–1796, USP 23/NF 18
- U. V. Banaker. Dissolution of modified dosage forms. Pharmaceutical Dissolution Testing. Marcel Dekker, New York 1992; 299–335
- Plaizier-Vercammen J., Van Molle M., Stepé K., Cherretté I. Eur. J. Pharm. Biopharm. 1992; 38: 145–149
- Baudoux M., Dechesne J. P., Delattre L. Pharm. Technol. Int. 1990; 2(11)18–26
- Lehmann K., Dreher D. Pharm. Tech. Int. 1979; 2(2)33–6; 55
- Lehmann K., Dreher D. Int. J. Pharm. Tech. Prod. Mfr. 1981; 2(4)31–43
- Schmidt P. C., Niemann P. Drug Dev. Ind. Pharm. 1992; 18(18)1969–1979
- Obara S., Mc Ginity J. W. Pharm. Res. 1994; 11(11)1562–1567
- Welling P. G., Dobrinska M. R. Dosing considerations and bioavailability assessment of controlled drug delivery systems. Controlled Drug Delivery: Fundamentals and Applications, 2nd ed., J. R. Robinson, V. H. L. Lee. Marcel Dekker, New York 1987; 253–289